Negotiated reimbursement rates for D7921 across 31 states, sourced from CMS Transparency in Coverage data. 288 rate records.
D7921 involves the collection and application of autologous blood concentrate, which is often used to enhance healing after dental procedures such as extractions or implants. Clinical indications include promoting tissue regeneration and reducing healing time. Proper documentation should include the method of blood collection, the volume obtained, and the application technique used. Reimbursement for D7921 can vary widely depending on the insurance provider and state regulations, with some payors recognizing it as a medically necessary procedure while others may classify it as an elective treatment, affecting coverage levels.
Reimbursement rates for D7921 vary significantly by state, payor, and provider network. The national average negotiated rate is $196. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
28+ more states available with Pro ↓